Nog een nieuwe studie van dit jaar:
https://www.bmj.com/content/365/bmj.l1204
Fina/duta verhoogt de kans op diabetes.
The risk of type 2 diabetes was increased by approximately 30% over 11 years in men with benign prostatic hyperplasia who received one of the 5?-reductase inhibitors on the market, finasteride or dutasteride compared with tamsulosin
Additional monitoring might be required for men starting these drugs, particularly in those with other risk factors for type 2 diabetes.
Extra belangrijke info:
Finasteride is also a 5br inhibitor. I feel this gets lost 99% of the time.
https://www.ncbi.nlm.nih.gov/m/pubmed/19515843/
5br, also known as AKR1D1, silencing drives insulin sensitivity, lipid has accumulation and fuels hepatocyte inflammation.
https://www.sciencedirect.com/scienc...26049519301441